Esperion Therapeutics (ESPR) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ESPR is expected to report earnings to fall 77.61% to -7 cents per share on November 05

Esperion Therapeutics ESPR Stock Earnings Reports

Q3'24

Est.

$-0.07

Q2'24

Missed

by $0.17

Q1'24

Beat

by $0.29

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.06

The last earnings report on August 12 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 2.73M shares outstanding, the current market capitalization sits at 495.94M.

View a ticker or compare two or three

Compare

ESPR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ESPR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3891 Ranchero Drive

Phone

+1 734 887-3903

Employees

240

Web

https://www.esperion.com